Agnieszka Markiewicz-Gospodarek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Agnieszka Markiewicz-Gospodarek has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Renata Markiewicz
Occupational Therapy Laboratory, Medical University of Lublin, 20-093 Lublin, Poland
14 shared publications - Bartosz Łoza
Department of Psychiatry, Medical University of Warsaw, 02-091 Warsaw, Poland
7 shared publications - Beata Dobrowolska
Department of Holistic Care and Management in Nursing, Faculty of Health Sciences Medical University of Lublin Lublin Poland
6 shared publications - Mateusz Trubalski
Student Scientific Association at the Department of Normal, Clinical and Imaging Anatomy, Medical University of Lublin, 20-090 Lublin, Poland
6 shared publications - Aleksandra Górska
Department of Human Anatomy, Medical University of Lublin, 4 Jaczewskiego St., 20-090 Lublin, Poland
5 shared publications - Zuzanna Chilimoniuk
Department of Laboratory Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland
4 shared publications
Latest Publications
- Open Access
- 29 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 380
Metabolic Plasticity in Schizophrenia: Clinical Rehabilitation Meets LC–MS Metabolomics and Neurofeedback
Metabolomics research in schizophrenia has revealed consistent alterations across multiple biochemical domains, including energy metabolism, lipid composition, amino acid pathways, and oxidative stress regulation. The most reproducible findings include the dysregulation of the tryptophan–kynurenine pathway, disturbances in arginine/nitric oxide metabolism, alterations in phospholipid and sphingolipid profiles, reduced glutathione (GSH) in the brain, and elevated lactate levels, suggesting mitochondrial dysfunction. Antipsychotic treatment itself modifies a wide range of metabolites, complicating biomarker discovery. Although no single biomarker has yet achieved clinical utility, systematic reviews and Mendelian randomization studies provide evidence for validated biomarker panels and potential causal links between peripheral metabolite signatures and schizophrenia risk. The aim of this study is to characterize metabolic changes in patients diagnosed with schizophrenia, where each group received different non-invasive therapeutic methods and was compared to patients continuing standard pharmacotherapy without modification. The study results show that schizophrenia is associated with systemic metabolic disturbances affecting energy, amino acid, lipid, and redox pathways. Further development of research in this area requires comprehensive and long-term studies integrated with modern imaging and analytical techniques.
- 29 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 380
Open AccessMetabolic Plasticity in Schizophrenia: Clinical Rehabilitation Meets LC–MS Metabolomics and Neurofeedback
Metabolomics research in schizophrenia has revealed consistent alterations across multiple biochemical domains, including energy metabolism, lipid composition, amino acid pathways, and oxidative stress regulation. The most reproducible findings include the dysregulation of the tryptophan–kynurenine pathway, disturbances in arginine/nitric oxide metabolism, alterations in phospholipid and sphingolipid profiles, reduced glutathione (GSH) in the brain, and elevated lactate levels, suggesting mitochondrial dysfunction. Antipsychotic treatment itself modifies a wide range of metabolites, complicating biomarker discovery. Although no single biomarker has yet achieved clinical utility, systematic reviews and Mendelian randomization studies provide evidence for validated biomarker panels and potential causal links between peripheral metabolite signatures and schizophrenia risk. The aim of this study is to characterize metabolic changes in patients diagnosed with schizophrenia, where each group received different non-invasive therapeutic methods and was compared to patients continuing standard pharmacotherapy without modification. The study results show that schizophrenia is associated with systemic metabolic disturbances affecting energy, amino acid, lipid, and redox pathways. Further development of research in this area requires comprehensive and long-term studies integrated with modern imaging and analytical techniques.
- Open Access
- 18 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11139
Oxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia
Schizophrenia is a complex neuropsychiatric disorder characterized by a diverse range of symptoms, including positive, negative symptoms such as alogia, anhedonia, avolition, and affective flattening, cognitive symptoms, and emotional symptoms as a separate domain. Emerging evidence suggests that oxidative stress and neuroinflammation play crucial roles in the etiopathogenesis of schizophrenia. The aim of this review is the interplay between oxidative stress—defined as an imbalance between reactive oxygen species (ROS) production and antioxidant defenses—and neuroinflammatory processes within the central nervous system. Studies indicate that elevated levels of oxidative markers and pro-inflammatory cytokines are commonly observed in individuals with schizophrenia, pointing to a potential pathophysiological link. The dysregulation of redox homeostasis may exacerbate neuroinflammatory responses, contributing to neuronal damage and the subsequent manifestation of psychiatric symptoms. Furthermore, genetic and environmental factors may interact with these biological processes, influencing individual susceptibility to schizophrenia. Understanding the mechanisms by which oxidative stress and neuroinflammation contribute to the development and progression of schizophrenia could pave the way for novel therapeutic strategies aimed at mitigating these pathological processes and improving patient outcomes.
- 18 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (22) , 11139
Open AccessOxidative Stress-Mediated Neuroinflammation in the Pathophysiology of Schizophrenia
Schizophrenia is a complex neuropsychiatric disorder characterized by a diverse range of symptoms, including positive, negative symptoms such as alogia, anhedonia, avolition, and affective flattening, cognitive symptoms, and emotional symptoms as a separate domain. Emerging evidence suggests that oxidative stress and neuroinflammation play crucial roles in the etiopathogenesis of schizophrenia. The aim of this review is the interplay between oxidative stress—defined as an imbalance between reactive oxygen species (ROS) production and antioxidant defenses—and neuroinflammatory processes within the central nervous system. Studies indicate that elevated levels of oxidative markers and pro-inflammatory cytokines are commonly observed in individuals with schizophrenia, pointing to a potential pathophysiological link. The dysregulation of redox homeostasis may exacerbate neuroinflammatory responses, contributing to neuronal damage and the subsequent manifestation of psychiatric symptoms. Furthermore, genetic and environmental factors may interact with these biological processes, influencing individual susceptibility to schizophrenia. Understanding the mechanisms by which oxidative stress and neuroinflammation contribute to the development and progression of schizophrenia could pave the way for novel therapeutic strategies aimed at mitigating these pathological processes and improving patient outcomes.
- Open Access
- 10 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4035
Neurocognitive, Clinical and Reelin Activity in Rehabilitation Using Neurofeedback Therapy in Patients with Schizophrenia
Introduction: Reelin is a neuropeptide responsible for the migration and positioning of pyramidal neurons, interneurons, and Purkinje cells. In adulthood, it still supports neuroplasticity, especially dendritic spines formation and glutamatergic neurotransmission. Genetic studies have confirmed the involvement of reelin system failure in the etiopathogenesis of mental diseases, including schizophrenia. Given the role of reelin in brain cytoarchitectonics and the regularly observed reduction in its activity in prefrontal areas in cases of schizophrenia, dysfunction of the reelin pathway fits the neurodevelopmental hypothesis of schizophrenia, both as a biochemical predisposition and/or the ultimate trigger of psychosis and as a biosocial factor determining the clinical course, and finally, as a potential target for disease monitoring and treatment. Aim: The purpose of this study was to examine associations of the reelin blood level with clinical and neurocognitive parameters during an intensive, structured neurofeedback therapy of patients with schizophrenia. Methods: Thirty-seven male patients with paranoid schizophrenia were randomly divided into two groups: a group with 3-month neurofeedback as an add-on to ongoing antipsychotic treatment (NF, N18), and a control group with standard social support and antipsychotic treatment (CON, N19). The reelin serum concentration, clinical and neurocognitive tests were compared between the groups. Results: After 3-month trial (T2), the reelin serum level increased in the NF group vs. the CON group. The negative and general symptoms of PANSS (Positive and Negative Syndrome Scale) were reduced significantly more in the NF group at T2, and the d2 (d2 Sustained Attention Test) and BCIS (Beck Cognitive Insight Scale) scores improved only in the NF group. The AIS scores improved more dynamically in the NF group, but not enough to differentiate them from the CON group at T2. Conclusions: The clinical and neurocognitive improvement within the 3-month NF add-on therapy trial was associated with a significant increase of reelin serum level in schizophrenia patients.
- 10 July 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (14) , 4035
Open AccessNeurocognitive, Clinical and Reelin Activity in Rehabilitation Using Neurofeedback Therapy in Patients with Schizophrenia
Introduction: Reelin is a neuropeptide responsible for the migration and positioning of pyramidal neurons, interneurons, and Purkinje cells. In adulthood, it still supports neuroplasticity, especially dendritic spines formation and glutamatergic neurotransmission. Genetic studies have confirmed the involvement of reelin system failure in the etiopathogenesis of mental diseases, including schizophrenia. Given the role of reelin in brain cytoarchitectonics and the regularly observed reduction in its activity in prefrontal areas in cases of schizophrenia, dysfunction of the reelin pathway fits the neurodevelopmental hypothesis of schizophrenia, both as a biochemical predisposition and/or the ultimate trigger of psychosis and as a biosocial factor determining the clinical course, and finally, as a potential target for disease monitoring and treatment. Aim: The purpose of this study was to examine associations of the reelin blood level with clinical and neurocognitive parameters during an intensive, structured neurofeedback therapy of patients with schizophrenia. Methods: Thirty-seven male patients with paranoid schizophrenia were randomly divided into two groups: a group with 3-month neurofeedback as an add-on to ongoing antipsychotic treatment (NF, N18), and a control group with standard social support and antipsychotic treatment (CON, N19). The reelin serum concentration, clinical and neurocognitive tests were compared between the groups. Results: After 3-month trial (T2), the reelin serum level increased in the NF group vs. the CON group. The negative and general symptoms of PANSS (Positive and Negative Syndrome Scale) were reduced significantly more in the NF group at T2, and the d2 (d2 Sustained Attention Test) and BCIS (Beck Cognitive Insight Scale) scores improved only in the NF group. The AIS scores improved more dynamically in the NF group, but not enough to differentiate them from the CON group at T2. Conclusions: The clinical and neurocognitive improvement within the 3-month NF add-on therapy trial was associated with a significant increase of reelin serum level in schizophrenia patients.
- Open Access
- 21 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 6842
Assessment of the Impact of Trace Essential Metals on Cancer Development
This study examines the impact of zinc, copper, cobalt, iron, and manganese on cancer development, considering their dual roles as potential promoters or inhibitors within tumorigenesis. A comprehensive analysis of existing literature and experimental data is conducted to elucidate the intricate relationship between these trace elements and cancer progression. The findings highlight the multifaceted effects of zinc, copper, cobalt, iron, and manganese on various aspects of cancer development, including cell proliferation, angiogenesis, and metastasis. Understanding the nuanced interactions between these trace elements and cancer could offer crucial insights into tumorigenesis mechanisms and facilitate the identification of novel biomarkers and therapeutic targets for cancer prevention and treatment strategies. This research underscores the importance of considering the roles of essential trace elements in cancer biology and may ultimately contribute to advancements in precision medicine approaches for combating cancer.
- 21 June 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (13) , 6842
Open AccessAssessment of the Impact of Trace Essential Metals on Cancer Development
This study examines the impact of zinc, copper, cobalt, iron, and manganese on cancer development, considering their dual roles as potential promoters or inhibitors within tumorigenesis. A comprehensive analysis of existing literature and experimental data is conducted to elucidate the intricate relationship between these trace elements and cancer progression. The findings highlight the multifaceted effects of zinc, copper, cobalt, iron, and manganese on various aspects of cancer development, including cell proliferation, angiogenesis, and metastasis. Understanding the nuanced interactions between these trace elements and cancer could offer crucial insights into tumorigenesis mechanisms and facilitate the identification of novel biomarkers and therapeutic targets for cancer prevention and treatment strategies. This research underscores the importance of considering the roles of essential trace elements in cancer biology and may ultimately contribute to advancements in precision medicine approaches for combating cancer.
- Open Access
- 29 December 2023
- Published by Stowarzyszenie Absolwentow i Przyjaciol Wydzialu Prawa Katolickiego Uniwersytetu Lubelskiego in Teka Komisji Prawniczej PAN Oddział w Lublinie
- Vol. 16 (2) , 491-506
The Level of Psychological Tension and Professional Burnout in Nurses Employed in Hospital Emergency Departments
Burnout syndrome is a collection of adverse symptoms that affect nursing staff employed in medical facilities. This syndrome is marked by a low mood, mental fatigue, and physical discomfort. Its emergence is impacted by strenuous work, organizational problems, and interpersonal conflicts. The aim of this study was to analyze the degree of mental burden and occupational burnout of nurses employed in Hospital Emergency Departments (ER). The data collection was based on the author’s questionnaire, as well as the MBI Maslach occupational burnout questionnaire and the Meister’s mental burden assessment questionnaire. The sample comprised 113 professionally active nurses employed in the HED. Conclusions: (1) the respondents exhibit a low and medium level of occupational burnout and mental workload, (2) socio-demographic factors, work experience and prevention methods do not affect the level of mental workload and occupational burnout, (3) employment in several workplaces causes a higher level of workload and professional burnout, (4) satisfaction with remuneration and support from colleagues is a key factor in reducing the risks of professional burnout. Burnout syndrome is a collection of adverse symptoms that affect nursing staff employed in medical facilities. This syndrome is marked by a low mood, mental fatigue, and physical discomfort. Its emergence is impacted by strenuous work, organizational problems, and interpersonal conflicts. The aim of this study was to analyze the degree of mental burden and occupational burnout of nurses employed in Hospital Emergency Departments (ER). The data collection was based on the author’s questionnaire, as well as the MBI Maslach occupational burnout questionnaire and the Meister’s mental burden assessment questionnaire. The sample comprised 113 professionally active nurses employed in the HED. Conclusions: (1) the respondents exhibit a low and medium level of occupational burnout and mental workload, (2) socio-demographic factors, work experience and prevention methods do not affect the level of mental workload and occupational burnout, (3) employment in several workplaces causes a higher level of workload and professional burnout, (4) satisfaction with remuneration and support from colleagues is a key factor in reducing the risks of professional burnout.
- 29 December 2023
- Published by Stowarzyszenie Absolwentow i Przyjaciol Wydzialu Prawa Katolickiego Uniwersytetu Lubelskiego in Teka Komisji Prawniczej PAN Oddział w Lublinie
- Vol. 16 (2) , 491-506
Open AccessThe Level of Psychological Tension and Professional Burnout in Nurses Employed in Hospital Emergency Departments
Burnout syndrome is a collection of adverse symptoms that affect nursing staff employed in medical facilities. This syndrome is marked by a low mood, mental fatigue, and physical discomfort. Its emergence is impacted by strenuous work, organizational problems, and interpersonal conflicts. The aim of this study was to analyze the degree of mental burden and occupational burnout of nurses employed in Hospital Emergency Departments (ER). The data collection was based on the author’s questionnaire, as well as the MBI Maslach occupational burnout questionnaire and the Meister’s mental burden assessment questionnaire. The sample comprised 113 professionally active nurses employed in the HED. Conclusions: (1) the respondents exhibit a low and medium level of occupational burnout and mental workload, (2) socio-demographic factors, work experience and prevention methods do not affect the level of mental workload and occupational burnout, (3) employment in several workplaces causes a higher level of workload and professional burnout, (4) satisfaction with remuneration and support from colleagues is a key factor in reducing the risks of professional burnout. Burnout syndrome is a collection of adverse symptoms that affect nursing staff employed in medical facilities. This syndrome is marked by a low mood, mental fatigue, and physical discomfort. Its emergence is impacted by strenuous work, organizational problems, and interpersonal conflicts. The aim of this study was to analyze the degree of mental burden and occupational burnout of nurses employed in Hospital Emergency Departments (ER). The data collection was based on the author’s questionnaire, as well as the MBI Maslach occupational burnout questionnaire and the Meister’s mental burden assessment questionnaire. The sample comprised 113 professionally active nurses employed in the HED. Conclusions: (1) the respondents exhibit a low and medium level of occupational burnout and mental workload, (2) socio-demographic factors, work experience and prevention methods do not affect the level of mental workload and occupational burnout, (3) employment in several workplaces causes a higher level of workload and professional burnout, (4) satisfaction with remuneration and support from colleagues is a key factor in reducing the risks of professional burnout.
- Open Access
- 11 December 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (12) , 1704
Reelin Signaling and Synaptic Plasticity in Schizophrenia
Recent research emphasizes the significance of studying the quality of life of schizophrenia patients, considering the complex nature of the illness. Identifying neuronal markers for early diagnosis and treatment is crucial. Reelin (RELN) stands out among these markers, with genetic studies highlighting its role in mental health. Suppression of RELN expression may contribute to cognitive deficits by limiting dendritic proliferation, affecting neurogenesis, and leading to improper neuronal circuits. Although the physiological function of reelin is not fully understood, it plays a vital role in hippocampal cell stratification and neuroglia formation. This analysis explores reelin’s importance in the nervous system, shedding light on its impact on mental disorders such as schizophrenia, paving the way for innovative therapeutic approaches, and at the same time, raises the following conclusions: increased methylation levels of the RELN gene in patients with a diagnosis of schizophrenia results in a multiple decrease in the expression of reelin, and monitoring of this indicator, i.e., methylation levels, can be used to monitor the severity of symptoms in the course of schizophrenia.
- 11 December 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (12) , 1704
Open AccessReelin Signaling and Synaptic Plasticity in Schizophrenia
Recent research emphasizes the significance of studying the quality of life of schizophrenia patients, considering the complex nature of the illness. Identifying neuronal markers for early diagnosis and treatment is crucial. Reelin (RELN) stands out among these markers, with genetic studies highlighting its role in mental health. Suppression of RELN expression may contribute to cognitive deficits by limiting dendritic proliferation, affecting neurogenesis, and leading to improper neuronal circuits. Although the physiological function of reelin is not fully understood, it plays a vital role in hippocampal cell stratification and neuroglia formation. This analysis explores reelin’s importance in the nervous system, shedding light on its impact on mental disorders such as schizophrenia, paving the way for innovative therapeutic approaches, and at the same time, raises the following conclusions: increased methylation levels of the RELN gene in patients with a diagnosis of schizophrenia results in a multiple decrease in the expression of reelin, and monitoring of this indicator, i.e., methylation levels, can be used to monitor the severity of symptoms in the course of schizophrenia.
- Open Access
- 29 September 2023
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 24, 218-245
Trace elements concentrations in drinking water – is there a risk for neurological or psychiatric disorders?
Introduction: Drinking water contaminated with heavy metals like arsenic, cadmium, nickel, mercury, chromium, zinc, lead, etc. is becoming a major health concern. Some trace elements have been linked to neurotoxic effects and an increased risk of neurodevelopmental disorders, although there is still an area for further investigations on how they may affect neurological and psychiatric illnesses. It is widely acknowledged that the generation of reactive oxygen species causes oxidative damage and other detrimental health effects, and is the main mechanism underlying heavy metal-induced toxicity in contaminated drinking water. The aim: The main objective of this narrative review was to summarize the current knowledge regarding the concentrations of chosen trace elements in drinking water and their possible relationship with neurological and psychiatric disorders. Material and method: The available literature was reviewed using PubMed, Scopus, and Web of Sciences platforms. The analysis included both reviews and original studies. Discussion: Some elements such as aluminum, arsenic, lithium, or nickel have been suggested to be risk factors for psychoneurological disorders. Further, studies suggest that some neurobehavioral disorders might be due to the collective action of metals in drinking water. Keywords: trace elements; drinking water; contamination; neurological disorder; psychiatric disorder
- 29 September 2023
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 24, 218-245
Open AccessTrace elements concentrations in drinking water – is there a risk for neurological or psychiatric disorders?
Introduction: Drinking water contaminated with heavy metals like arsenic, cadmium, nickel, mercury, chromium, zinc, lead, etc. is becoming a major health concern. Some trace elements have been linked to neurotoxic effects and an increased risk of neurodevelopmental disorders, although there is still an area for further investigations on how they may affect neurological and psychiatric illnesses. It is widely acknowledged that the generation of reactive oxygen species causes oxidative damage and other detrimental health effects, and is the main mechanism underlying heavy metal-induced toxicity in contaminated drinking water. The aim: The main objective of this narrative review was to summarize the current knowledge regarding the concentrations of chosen trace elements in drinking water and their possible relationship with neurological and psychiatric disorders. Material and method: The available literature was reviewed using PubMed, Scopus, and Web of Sciences platforms. The analysis included both reviews and original studies. Discussion: Some elements such as aluminum, arsenic, lithium, or nickel have been suggested to be risk factors for psychoneurological disorders. Further, studies suggest that some neurobehavioral disorders might be due to the collective action of metals in drinking water. Keywords: trace elements; drinking water; contamination; neurological disorder; psychiatric disorder
- Open Access
- 29 September 2023
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 24, 218-245
Trace elements concentrations in drinking water – is there a risk for neurological or psychiatric disorders?
- 29 September 2023
- Published by Medical University of Lublin in Current Problems of Psychiatry
- Vol. 24, 218-245
Open AccessTrace elements concentrations in drinking water – is there a risk for neurological or psychiatric disorders?
- Open Access
- 5 June 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (6) , 911
Distribution of Iron, Copper, Zinc and Cadmium in Glia, Their Influence on Glial Cells and Relationship with Neurodegenerative Diseases
Recent data on the distribution and influence of copper, zinc and cadmium in glial cells are summarized. This review also examines the relationship between those metals and their role in neurodegenerative diseases like Alzheimer disease, multiple sclerosis, Parkinson disease and Amyotrophic lateral sclerosis, which have become a great challenge for today’s physicians. The studies suggest that among glial cells, iron has the highest concentration in oligodendrocytes, copper in astrocytes and zinc in the glia of hippocampus and cortex. Previous studies have shown neurotoxic effects of copper, iron and manganese, while zinc can have a bidirectional effect, i.e., neurotoxic but also neuroprotective effects depending on the dose and disease state. Recent data point to the association of metals with neurodegeneration through their role in the modulation of protein aggregation. Metals can accumulate in the brain with aging and may be associated with age-related diseases.
- 5 June 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (6) , 911
Open AccessDistribution of Iron, Copper, Zinc and Cadmium in Glia, Their Influence on Glial Cells and Relationship with Neurodegenerative Diseases
Recent data on the distribution and influence of copper, zinc and cadmium in glial cells are summarized. This review also examines the relationship between those metals and their role in neurodegenerative diseases like Alzheimer disease, multiple sclerosis, Parkinson disease and Amyotrophic lateral sclerosis, which have become a great challenge for today’s physicians. The studies suggest that among glial cells, iron has the highest concentration in oligodendrocytes, copper in astrocytes and zinc in the glia of hippocampus and cortex. Previous studies have shown neurotoxic effects of copper, iron and manganese, while zinc can have a bidirectional effect, i.e., neurotoxic but also neuroprotective effects depending on the dose and disease state. Recent data point to the association of metals with neurodegeneration through their role in the modulation of protein aggregation. Metals can accumulate in the brain with aging and may be associated with age-related diseases.
- Open Access
- 2 May 2023
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 30 (2) , 315-321
Brain-derived neurotrophic factor and matrix metalloproteinase-9 activity during rehabilitation therapy of schizophrenic patients – environmental pilot study
Introduction and objective: The aim of the study was to evaluate the peripheral level of brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) during rehabilitation therapy, combined with neurofeedback in schizophrenic patients, and to investigate whether these...
- 2 May 2023
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
- Vol. 30 (2) , 315-321
Open AccessBrain-derived neurotrophic factor and matrix metalloproteinase-9 activity during rehabilitation therapy of schizophrenic patients – environmental pilot study
Introduction and objective: The aim of the study was to evaluate the peripheral level of brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) during rehabilitation therapy, combined with neurofeedback in schizophrenic patients, and to investigate whether these...